Skip to main content
All lobbying clients

ESTEVE PHARMACEUTICALS, S.A.

Lobbying client · filed 2026 to 2026

Pharmaceutical manufacturer of highly specialized medicines in areas of a high unmet need.

$20,000 Reported spend
3 Filings counted
1 Firms hired
0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (71935), not by name.

 Firms hired 1
 Reported by year 1 year
  • 2026 $20,000 3 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 1
  • Centers For Medicare and Medicaid Services (CMS) 2
 Recent filings 3 total
Q2
ARNOLD & PORTER KAYE SCHOLER LLP
2nd Quarter (Apr 1 - June 30) 2026 · $10,000 income · posted Jul 20, 2026
View → Q1
ARNOLD & PORTER KAYE SCHOLER LLP
1st Quarter (Jan 1 - Mar 31) 2026 · $10,000 income · posted Apr 20, 2026
View → RR
ARNOLD & PORTER KAYE SCHOLER LLP
1st Quarter (Jan 1 - Mar 31) 2026 · posted Mar 23, 2026
View →
 Foreign entities disclosed 3
  • ESTEVE HEALTHCARE, S.L. Spain named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0
  • GRUPO ESTEVE LIFESCIENCES, S.L. (MAJORITY OWNER OF ESTEVE HEALTHCARE, S.L.) Spain named on 1 filing · highest disclosed ownership 74% · largest disclosed contribution $0
  • LUBEA CATAMAN GMBH & CO.KG (MINORITY OWNER OF ESTEVE HEALTHCARE, S.L.) Germany named on 1 filing · highest disclosed ownership 26% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem